| 000 | 01608 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517070457.0 | ||
| 264 | 0 | _c20170728 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1365-2265 | ||
| 024 | 7 |
_a10.1111/cen.12999 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBullock, Martyn | |
| 245 | 0 | 0 |
_aTERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas. _h[electronic resource] |
| 260 |
_bClinical endocrinology _c08 2016 |
||
| 300 |
_a283-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCarcinoma, Papillary _xdiagnosis |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTelomerase _xgenetics |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xdiagnosis |
| 700 | 1 | _aRen, Yan | |
| 700 | 1 | _aO'Neill, Christine | |
| 700 | 1 | _aGill, Anthony | |
| 700 | 1 | _aAniss, Adam | |
| 700 | 1 | _aSywak, Mark | |
| 700 | 1 | _aSidhu, Stan | |
| 700 | 1 | _aDelbridge, Leigh | |
| 700 | 1 | _aLearoyd, Diana | |
| 700 | 1 | _ade Vathaire, Florent | |
| 700 | 1 | _aRobinson, Bruce G | |
| 700 | 1 | _aClifton-Bligh, Roderick J | |
| 773 | 0 |
_tClinical endocrinology _gvol. 85 _gno. 2 _gp. 283-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cen.12999 _zAvailable from publisher's website |
| 999 |
_c25542104 _d25542104 |
||